These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4144007)

  • 1. On the binding of aflatoxin B 1 and its metabolites to hepatic microsomes.
    Gurtoo HL
    Biochem Biophys Res Commun; 1973 Feb; 50(3):649-55. PubMed ID: 4144007
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative metabolism of aflatoxin B1 by rat liver microsomes in vitro and its effect on lipid peroxidation.
    Raj HG; Santhanam K; Gupta RP; Venkitasubramanian TA
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):703-6. PubMed ID: 4153624
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of aflatoxin B 1 metabolite with rat liver RNA.
    Gurtoo HL; Dave C
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):635-45. PubMed ID: 4144818
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial purification and properties of cytochromes P-450 and P-448 from rat liver microsomes.
    Levin W; Lu AY; Ryan D; West S; Kuntzman R; Conney AH
    Arch Biochem Biophys; 1972 Dec; 153(2):543-53. PubMed ID: 4662099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spectrophotometric investigations of aflatoxin B1 binding to rat liver microsomes (author's transl)].
    Norpoth K; Bösenberg H; Witting U; Kruse P; Grass S
    Hoppe Seylers Z Physiol Chem; 1974 Jul; 355(7):867-71. PubMed ID: 4435757
    [No Abstract]   [Full Text] [Related]  

  • 6. On the nature of the binding of aflatoxin B2a to rat hepatic microsomes.
    Gurtoo HL; Dahms R
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):107-18. PubMed ID: 4438820
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites.
    Gurtoo HL; Dave CV
    Cancer Res; 1975 Feb; 35(2):382-9. PubMed ID: 234034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon tetrachloride-induced protection against carbon tetrachloride toxicity. The role of the liver microsomal drug-metabolizing system.
    Glende EA
    Biochem Pharmacol; 1972 Jun; 21(12):1697-702. PubMed ID: 4405417
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytochrome P-450-linked monooxygenase system and drug-induced spectral interactions in human liver microsomes.
    Pelkonen O; Kaltiala EH; Larmi TK; Kärki NT
    Chem Biol Interact; 1974 Sep; 9(3):205-16. PubMed ID: 4426109
    [No Abstract]   [Full Text] [Related]  

  • 10. Imipramine and chlorpromazine in hepatic microsomal systems.
    Perel JM; O'Brien L; Black NB; Bellward GD; Dayton PG
    Adv Biochem Psychopharmacol; 1974; 9(0):201-12. PubMed ID: 4836204
    [No Abstract]   [Full Text] [Related]  

  • 11. The stimulation of lipid peroxidation produced by dimethylnitrosamine in rat liver microsomes in vitro: the effects of promethazine and inhibitors of drug metabolism, and a comparison with previous studies using carbon tetrachloride.
    Jose PJ; Slater TF
    Xenobiotica; 1973 Jun; 3(6):357-66. PubMed ID: 4148105
    [No Abstract]   [Full Text] [Related]  

  • 12. The complexity of the inhibitory action of dicoumarol on the mixed function oxidase system of rat liver microsomes.
    Wissing F; Christensen F
    Biochem Pharmacol; 1973 Mar; 22(5):581-9. PubMed ID: 4120818
    [No Abstract]   [Full Text] [Related]  

  • 13. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 14. Sedimentation and other properties of the reconstituted liver microsomal mixed-function oxidase system containing cytochrome P-450, reduced triphosphopyridine nucleotide-cytochrome P-450 reductase, and phosphatidylcholine.
    Autor AP; Kaschnitz RM; Heidema JK; Coon MJ
    Mol Pharmacol; 1973 Jan; 9(1):93-104. PubMed ID: 4405520
    [No Abstract]   [Full Text] [Related]  

  • 15. Aflaxation B1 hydroxylation by hepatic microsomal preparations from the rhesus monkey.
    Krieger RI; Salhab AS; Dalezios JI; Hsieh DP
    Food Cosmet Toxicol; 1975 Apr; 13(2):211-9. PubMed ID: 236980
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of the hepatic and pulmonary microsomal mixed-function oxidase systems in the rabbit.
    Bend JR; Hook GE; Easterling RE; Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1972 Oct; 183(1):206-17. PubMed ID: 4404113
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of extra bound cytochrome b-5 on cytochrome P-450-dependent enzyme activities in liver microsomes.
    Hrycay EG; Estabrook RW
    Biochem Biophys Res Commun; 1974 Sep; 60(2):771-8. PubMed ID: 4153715
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of dietary iron levels on hepatic drug metabolism in vivo and in vitro in the rat.
    Becking GC
    Biochem Pharmacol; 1972 Jun; 21(11):1585-93. PubMed ID: 4405218
    [No Abstract]   [Full Text] [Related]  

  • 19. Dietary fatty acid-induced alterations of hepatic microsomal drug metabolism.
    Norred WP; Wade AE
    Biochem Pharmacol; 1972 Nov; 21(21):2887-97. PubMed ID: 4646808
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative demethylation of 14C-griseofulvin by liver microsomes of rats and mice.
    Chang RL; Symchowicz S; Lin CC
    Biochem Pharmacol; 1973 Jun; 22(11):1389-92. PubMed ID: 4146984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.